EUVIMEDSkopri EUVIMED
Crossref

Gut microbiota‐derived nicotinamide mononucleotide alleviates acute pancreatitis by activating pancreatic SIRT3 signalling

Li-Wei Liu, Yu Xie, Guan-Qun Li, Tao Zhang, Yu-Hang Sui, Zhong-Jie Zhao, Yang-Yang Zhang, Wen-Bo Yang, Xing-Long Geng, Dong-Bo Xue, Hua Chen, Yong-Wei Wang and 5 more

British Journal of Pharmacology · 2023-03 · 180 (5) · 647-666

DOI: 10.1111/bph.15980 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2022-12-04. Written by Li-Wei Liu and 16 co-authors. Institution: Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Major MEDLINE topics: Pancreatitis, Sirtuin 3, Gastrointestinal Microbiome. Cited 56 times so far (Crossref); 56 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province, Youth Innovation Talent Training Program of the General Undergraduate Colleges and Universities in Heilongjiang Province.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Gut microbiota dysbiosis induced by acute pancreatitis (AP) exacerbates pancreatic injury and systemic inflammatory responses. The alleviation of gut microbiota dysbiosis through faecal microbiota transplantation (FMT) is considered a potential strategy to reduce tissue damage and inflammation in many clinical disorders. Here, we aim to investigate the effect of gut microbiota and microbiota‐derived metabolites on AP and further clarify the mechanisms associated with pancreatic damage and inflammation. Experimental Approach AP rat and mouse models were established by administration of caerulein or sodium taurocholate in vivo. Pancreatic acinar cells were exposed to caerulein and lipopolysaccharide in vitro to simulate AP. Key Results Normobiotic FMT alleviated AP‐induced gut microbiota dysbiosis and ameliorated the severity of AP, including mitochondrial dysfunction, oxidative damage and inflammation. Normobiotic FMT induced higher levels of NAD + (nicotinamide adenine dinucleotide)‐associated metabolites, particularly nicotinamide mononucleotide (NMN). NMN administration mitigated AP‐mediated mitochondrial dysfunction, oxidative damage and inflammation by increasing pancreatic NAD + levels. Similarly, overexpression of the NAD + ‐dependent mitochondrial deacetylase sirtuin 3 (SIRT3) alleviated the severity of AP. Furthermore, SIRT3 deacetylated peroxiredoxin 5 (PRDX5) and enhanced PRDX5 protein expression, thereby promoting its antioxidant and anti‐inflammatory activities in AP. Importantly, normobiotic FMT‐mediated NMN metabolism induced SIRT3–PRDX5 pathway activation during AP. Conclusion and Implications Gut microbiota‐derived NMN alleviates the severity of AP by activating the SIRT3–PRDX5 pathway. Normobiotic FMT could be served as a potential strategy for AP treatment.

Subjects

MeSH terms (MEDLINE)

PancreatitisSirtuin 3Gastrointestinal MicrobiomeMiceRatsAnimalsNicotinamide MononucleotideNADDysbiosisCeruletideAcute DiseaseInflammation

Author keywords

PRDX5SIRT3acute pancreatitisfecal microbiota transplantationnicotinamide mononucleotideoxidative damage

Substances

Nicotinamide MononucleotideSirtuin 3NADCeruletideSirt3 protein, mouse

Authors and institutions

  • Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin, China.

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Heilongjiang Province
  • Youth Innovation Talent Training Program of the General Undergraduate Colleges and Universities in Heilongjiang Province

Cite

APA

Liu, L. W., Xie, Y., Li, G. Q., Zhang, T., Sui, Y. H., Zhao, Z. J., Zhang, Y. Y., Yang, W. B., Geng, X. L., Xue, D. B., Chen, H., Wang, Y. W., Lu, T. Q., Shang, L. R., Li, Z. B., Li, L., & Sun, B. (2023). Gut microbiota‐derived nicotinamide mononucleotide alleviates acute pancreatitis by activating pancreatic SIRT3 signalling. British Journal of Pharmacology, 180(5), 647-666. https://doi.org/10.1111/bph.15980

Vancouver

Liu LW, Xie Y, Li GQ, Zhang T, Sui YH, Zhao ZJ, et al. Gut microbiota‐derived nicotinamide mononucleotide alleviates acute pancreatitis by activating pancreatic SIRT3 signalling. British Journal of Pharmacology. 2023;180(5):647-666. doi:10.1111/bph.15980

BibTeX
@article{Liu2023,
  author = {Liu, Li-Wei and Xie, Yu and Li, Guan-Qun and Zhang, Tao and Sui, Yu-Hang and Zhao, Zhong-Jie and Zhang, Yang-Yang and Yang, Wen-Bo and Geng, Xing-Long and Xue, Dong-Bo and Chen, Hua and Wang, Yong-Wei and Lu, Tian-Qi and Shang, Li-Ren and Li, Zhi-Bo and Li, Le and Sun, Bei},
  title = {Gut microbiota‐derived nicotinamide mononucleotide alleviates acute pancreatitis by activating pancreatic SIRT3 signalling},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {5},
  pages = {647--666},
  doi = {10.1111/bph.15980}
}
Start for free →